3,892 followers
New Research: Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies: Introduction: The glycoengineered type II anti-CD20 monoclonal antibody obinutuzumab has been licensed for treatment in follicular… https://t.co/9ivsmFgWOb